Showing results (891-900 of 956) with videos related to

Sort By:
Pageof 96
Future Oncology (London, England)|April 15, 2026
Phase II basket study of brigatinib for ALK fusion-positive solid tumors: WJOG15221M/ALLBREAK (a decentralized clinical trial design)Tomoki Sakakida, Toshiki Masuishi, Takuma Onoe, et al.
Plos One|June 23, 2017
The G8 screening tool enhances prognostic value to ECOG performance status in elderly cancer patients: A retrospective, single institutional studyMasahiro Takahashi, Masanobu Takahashi, Keigo Komine, et al.
International Journal of Molecular Sciences|February 11, 2023
Association of High LAT1 Expression with Poor Prognosis and Recurrence in Colorectal Cancer Patients Treated with Oxaliplatin-Based Adjuvant ChemotherapyYuta Shibasaki, Takehiko Yokobori, Makoto Sohda, et al.
Japanese Journal of Infectious Diseases|July 14, 2015
Antibiotic Resistance of Campylobacter jejuni and C. coli Isolated from Children with Diarrhea in Thailand and JapanNgan Thi Kim Pham, Aksara Thongprachum, Dinh Nguyen Tran, et al.
Cancer Science|August 17, 2022
Chronological improvement in precision oncology implementation in JapanKuniko Sunami, Yoichi Naito, Keigo Komine, et al.
Gastroenterology|December 7, 2007
Roles of calcitonin gene-related peptide in maintenance of gastric mucosal integrity and in enhancement of ulcer healing and angiogenesisTakashi Ohno, Youichiro Hattori, Rie Komine, et al.
Cancer Reports (Hoboken, N.J.)|June 17, 2026
Assessment of Multiple Prognostic Scores in Patients With Metastatic Renal Cell Carcinoma Receiving First-Line, Immune-Based CombinationsHiromichi Sakurai, Masanobu Shiga, Shuya Kandori, et al.
Communications Biology|January 17, 2025
Prenatal inflammation impairs early CD11c-positive microglia induction and delays myelination in neurodevelopmental disordersKazuya Fuma, Yukako Iitani, Kenji Imai, et al.
The Tohoku Journal of Experimental Medicine|June 26, 2018
Efficacy and Safety of Trastuzumab in Combination with S-1 and Cisplatin Therapy for Japanese Patients with HER2-Positive Advanced Gastric Cancer: Retrospective AnalysisAkira Okita, Hiroo Imai, Masahiro Takahashi, et al.
BMC Cancer|August 22, 2023
NEXUS trial: a multicenter phase II clinical study evaluating the efficacy and safety of the perioperative use of encorafenib, binimetinib, and cetuximab in patients with previously untreated surgically resectable BRAF V600E mutant colorectal oligometastasesShin Kobayashi, Hideaki Bando, Akinobu Taketomi, et al.
Pageof 96